Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1658PDF: 1104HTML: 478 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2338PDF: 851HTML: 450 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2398PDF: 1037HTML: 7696Untitled: 301Fig2: 205Fig3: 195Fig4: 207 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2510PDF: 1221HTML: 1066 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1467PDF: 723HTML: 1186Untitled: 202Untitled: 166Untitled: 156Untitled: 169Untitled: 180 -
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4058PDF: 1097HTML: 3897Untitled: 187Cneo. Fig.1: 125Untitled: 120Untitled: 145Untitled: 154 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4321PDF: 1984HTML: 5517Table 1: 234 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4581PDF: 1521HTML: 8537 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1742PDF: 1139HTML: 167 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2342PDF: 1201HTML: 2606Study of serum haptoglobin level in thalassemia: 384Figures: 210 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1797PDF: 583HTML: 250 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7846PDF: 2489HTML: 2118Table 1.: 246Table 2.: 257Table 3.: 238Table 4.: 233 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2002PDF: 821HTML: 580 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9327PDF: 6205HTML: 88074Fig.1b: 221Fig.1c: 222Fig.2a: 205Fig.2b: 204Fig.4: 226Fig.2c: 206Fig.3: 208Tab.1: 262Tab.2: 240Tab.3: 223Tab.4: 254Fig1a: 219 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
574PDF: 280HTML: 121 -
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
2007Suppl. Files: 922HTML: 591PDF: 791 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3793PDF: 935HTML: 6875 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2438PDF: 1241HTML: 3898 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4957PDF: 2926HTML: 2345 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4671PDF: 1991HTML: 18161 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3035PDF: 1058HTML: 1356 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2105PDF: 123HTML: 32 -
WHAT ARE FUNGAL INFECTIONS?
4325PDF: 2475HTML: 27699de Pauw: 263 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1359PDF: 1083HTML: 427







